Related Experiment Videos
Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists
1Department of Chemistry, AstraZeneca R&D Montréal, Saint-Laurent, Québec, Canada. daniel.page@astrazeneca.com
Bioorganic & Medicinal Chemistry Letters
|February 15, 2000
Abstract:
A series of Dmt-Tic analogues with substitution on the Tic aromatic ring has been synthesized and evaluated for opioid receptor affinity and activation. Incorporation of large hydrophobic groups at position 7 of Tic did not greatly alter the delta opioid receptor binding affinities of the dipeptides whereas substitution at position 6 substantially diminished their affinity. These modified Dmt-Tic peptides showed binding affinities as low as 2.5 nM with up to 500-fold selectivity for the delta versus mu opioid receptor and proved to be delta receptor antagonists.